Page last updated: 2024-08-23

paclitaxel and Esophageal Dysmotility

paclitaxel has been researched along with Esophageal Dysmotility in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DiCaudo, DJ; Farhey, Y; Griffing, WL; Martorano, LM; Trotter, SC; Winkelmann, JC; Winkelmann, RR; Yiannias, JA	1

Reviews

1 review(s) available for paclitaxel and Esophageal Dysmotility

Article	Year
Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis. International journal of dermatology, 2016, Volume: 55, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Esophageal Motility Disorders; Female; Humans; Immunohistochemistry; Middle Aged; Myositis; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prognosis; Raynaud Disease; Risk Assessment; Scleroderma, Systemic; Treatment Outcome	2016

Article

Year

Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis.

International journal of dermatology, 2016, Volume: 55, Issue:1

Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Esophageal Motility Disorders; Female; Humans; Immunohistochemistry; Middle Aged; Myositis; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prognosis; Raynaud Disease; Risk Assessment; Scleroderma, Systemic; Treatment Outcome

2016